Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist

Involvement of the NO/sGC/cGMP/K + channels pathway in vascular relaxation evoked by two non-quinazoline α 1 -adrenoceptor antagonists

(2018) Monika Kubacka et al.   BIOMEDICINE & PHARMACOTHERAPY

Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation

(2016) Jozine M. ter Maaten et al.   EUROPEAN JOURNAL OF HEART FAILURE

Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension

(2016) Hardik Gandhi et al.   Pharmacological Reports

Antidepressant-like activity of aroxyalkyl derivatives of 2-methoxyphenylpiperazine and evidence for the involvement of serotonin receptor subtypes in their mechanism of action

(2016) Monika Kubacka et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Inflammation Markers in Essential Hypertension

(2014) Dimitrios Tsounis et al.   Medicinal Chemistry

Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension

(2014) Quynh N. Dinh et al.   Biomed Research International

The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine

(2012) Monika Kubacka et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Renoprotective Effects of Sildenafil in DOCA-Salt Hypertensive Rats

(2012) Eun Hui Bae et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor

(2012) Bhupesh Sharma et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Endothelial dysfunction as a cellular mechanism for vascular failure

(2011) Tetsuaki Hirase et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells

(2011) Zu-Yau Lin et al.   BIOMEDICINE & PHARMACOTHERAPY

L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin–angiotensin–aldosterone system in deoxycorticosterone acetate-salt hypertensive rats

(2011) Hiroe Toba et al.   HYPERTENSION RESEARCH

Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?

(2010) Neil Chapman et al.   JOURNAL OF HYPERTENSION

Apoptosis induction by doxazosin and other quinazoline α1-adrenoceptor antagonists: a new mechanism for cancer treatment?

(2009) Natasha Kyprianou et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats

(2009) E. H. Bae et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial

(2008) Neil Chapman et al.   CIRCULATION

Endothelium-Specific GTP Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression in Salt-Sensitive Low-Renin Hypertension

(2008) Yan-Hua Du et al.   CIRCULATION

The role of lipoic acid in prevention of nitroglycerin tolerance

(2008) Magdalena Dudek et al.   EUROPEAN JOURNAL OF PHARMACOLOGY